Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVX001 3% ointment pilot study in atopic dermatitis
2016-003013-96Phase 2Completed
- Sponsor
- Avexxin AS
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AVX001 in atopic dermatitis (AD), sponsored by Avexxin AS. Started Jul 2016; status: completed.
02
Drugs
AVX001
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2016-003013-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003013-96.